These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 8111428

  • 21. Interleukin-1 and interleukin-1 receptor antagonist.
    Dinarello CA.
    Nutrition; 1995; 11(5 Suppl):492-4. PubMed ID: 8748206
    [Abstract] [Full Text] [Related]

  • 22. Chronic inflammatory joint diseases: natural inhibitors of interleukin 1 and tumor necrosis factor alpha.
    Dayer JM.
    J Rheumatol Suppl; 1991 Feb; 27():71-5. PubMed ID: 2027136
    [Abstract] [Full Text] [Related]

  • 23. [Interleukin-1 and other proinflammatory cytokines].
    Miossec P.
    Pediatrie; 1991 Feb; 46(2):135-9. PubMed ID: 1646428
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.
    Cahlin C, Körner A, Axelsson H, Wang W, Lundholm K, Svanberg E.
    Cancer Res; 2000 Oct 01; 60(19):5488-93. PubMed ID: 11034092
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation.
    Dinarello CA.
    Curr Opin Pharmacol; 2004 Aug 01; 4(4):378-85. PubMed ID: 15251132
    [Abstract] [Full Text] [Related]

  • 27. Pathogenesis of rheumatoid arthritis: targeting cytokines.
    Zwerina J, Redlich K, Schett G, Smolen JS.
    Ann N Y Acad Sci; 2005 Jun 01; 1051():716-29. PubMed ID: 16127012
    [Abstract] [Full Text] [Related]

  • 28. Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion.
    Pan JZ, Ni L, Sodhi A, Aguanno A, Young W, Hart RP.
    J Neurosci Res; 2002 May 01; 68(3):315-22. PubMed ID: 12111861
    [Abstract] [Full Text] [Related]

  • 29. [Cytokines and antagonists in septic shock].
    Girardin E, Dayer JM.
    Schweiz Med Wochenschr; 1993 Mar 20; 123(11):480-91. PubMed ID: 8386392
    [Abstract] [Full Text] [Related]

  • 30. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
    Ounissi-Benkalha H, Pelletier JP, Tardif G, Mineau F, Jolicoeur FC, Ranger P, Martel-Pelletier J.
    J Rheumatol; 1996 Jan 20; 23(1):16-23. PubMed ID: 8838503
    [Abstract] [Full Text] [Related]

  • 31. Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha.
    Bouchelouche K, Alvarez S, Horn T, Nordling J, Bouchelouche P.
    Urology; 2006 Jan 20; 67(1):214-9. PubMed ID: 16413378
    [Abstract] [Full Text] [Related]

  • 32. The mode of action of cytokine inhibitors.
    Arend WP.
    J Rheumatol Suppl; 2002 Sep 20; 65():16-21. PubMed ID: 12236617
    [Abstract] [Full Text] [Related]

  • 33. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G.
    Arthritis Rheum; 2004 Jan 20; 50(1):277-90. PubMed ID: 14730626
    [Abstract] [Full Text] [Related]

  • 34. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
    Meyer O.
    Bull Acad Natl Med; 2003 Jan 20; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
    [Abstract] [Full Text] [Related]

  • 35. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.
    Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC.
    J Immunol; 1999 Oct 01; 163(7):3963-8. PubMed ID: 10490998
    [Abstract] [Full Text] [Related]

  • 36. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome.
    Dinarello CA, Gelfand JA, Wolff SM.
    JAMA; 1993 Apr 14; 269(14):1829-35. PubMed ID: 8459516
    [Abstract] [Full Text] [Related]

  • 37. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.
    Gogos CA, Drosou E, Bassaris HP, Skoutelis A.
    J Infect Dis; 2000 Jan 14; 181(1):176-80. PubMed ID: 10608764
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. New approaches to modify glomerular inflammation.
    Kluth DC, Rees AJ.
    J Nephrol; 1999 Jan 14; 12(2):66-75. PubMed ID: 10378661
    [Abstract] [Full Text] [Related]

  • 40. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK, Rivier C.
    J Neuroendocrinol; 1998 May 14; 10(5):353-62. PubMed ID: 9663649
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.